HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Buscombe Selected Research

lanreotide (Somatuline)

4/2002In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Buscombe Research Topics

Disease

4Inflammation (Inflammations)
01/2018 - 04/2013
3Carcinoma (Carcinomatosis)
05/2016 - 04/2002
3Neoplasms (Cancer)
09/2008 - 04/2002
2Infections
01/2018 - 04/2013
2Hepatocellular Carcinoma (Hepatoma)
03/2008 - 12/2007
1Obesity
01/2022
1Hyperphagia (Overeating)
01/2022
1Prostatic Neoplasms (Prostate Cancer)
04/2021
1Neoplasm Metastasis (Metastasis)
04/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1Pituitary Neoplasms (Pituitary Adenoma)
11/2016
1Acromegaly
11/2016
1Vasculitis (Vasculitides)
11/2015
1Carcinoid Tumor (Carcinoid)
02/2013
1Infarction (Infarctions)
07/2012
1Cardiovascular Diseases (Cardiovascular Disease)
07/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2012
1Chronic Renal Insufficiency
01/2010
1Lymphoma (Lymphomas)
12/2009
1Thyroid Neoplasms (Thyroid Cancer)
09/2008
1Hyperthyroidism
09/2008
1Acquired Immunodeficiency Syndrome (AIDS)
05/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2007
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2002
1Plasmacytoma
04/2002
1Multiple Myeloma
04/2002

Drug/Important Bio-Agent (IBA)

2pentetreotide (OctreoScan)FDA Link
02/2013 - 05/2008
2Iodine-131IBA
12/2009 - 09/2008
2Radioisotopes (Radionuclides)IBA
05/2008 - 04/2002
2Somatostatin Receptors (Somatostatin Receptor)IBA
05/2008 - 04/2002
2Rhenium-188IBA
03/2008 - 12/2007
2Ethiodized Oil (Ethiodol)FDA Link
03/2008 - 12/2007
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
01/2022
1Radium-223IBA
04/2021
1Citric Acid (Citrate)FDA LinkGeneric
01/2018
1Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2015
1LigandsIBA
01/2014
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2013
1HomocysteineIBA
07/2012
1CalciumIBA
01/2010
1BariumIBA
01/2010
1lanthanum carbonate (Fosrenol)FDA Link
01/2010
1LanthanumIBA
01/2010
1MineralsIBA
01/2010
1Phosphates (Orthophosphate)IBA
01/2010
1Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2009
1sodium-iodide symporter (sodium iodide symporter)IBA
09/2008
1IsotopesIBA
09/2008
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
09/2008
1pasireotideIBA
05/2008
1Proteins (Proteins, Gene)FDA Link
12/2007
1Glucose (Dextrose)FDA LinkGeneric
04/2002
1Deoxyglucose (2 Deoxy D glucose)IBA
04/2002
1lanreotide (Somatuline)FDA Link
04/2002
1Peptides (Polypeptides)IBA
04/2002
1Peptide Receptors (Peptide Receptor)IBA
04/2002

Therapy/Procedure

5Therapeutics
04/2021 - 04/2002
4Radiotherapy
11/2016 - 04/2007
2Radioimmunotherapy
12/2009 - 07/2009
1Drug Therapy (Chemotherapy)
09/2008
1Intra-Arterial Injections
12/2007
1Stem Cell Transplantation
04/2002